1. DOP40 Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib. (30th January 2023) Authors: Dubinsky, M C; D'Haens, G; Dewit, O; Juillerat, P; Panaccione, R; Fujii, T; Lacerda, A P; Dubcenco, E; Anyanwu, S; Doshi, C; Mallick, M; Garrison, A; Liu, J; Loftus Jr, E V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study. (26th February 2022) Authors: Cottron, C; Treton, X; Altwegg, R; Reenaers, C; Amiot, A; Fumery, M; Vuitton, L; Peyrin-Biroulet, L; Bouguen, G; Dewit, O; Nancey, S; Caillo, L; Roblin, X; Beylot-Barry, M; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 8(2022) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. Issue 2 (4th January 2017) Authors: Laharie, D; Bourreille, A; Branche, J; Allez, M; Bouhnik, Y; Filippi, J; Zerbib, F; Savoye, G; Vuitton, L; Moreau, J; Amiot, A; Cosnes, J; Ricart, E; Dewit, O; Lopez-Sanroman, A; Fumery, M; Carbonnel, F; Bommelaer, G; Coffin, B; Roblin, X Journal: Gut Issue: Volume 67:Issue 2(2018) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP28 A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD). (21st January 2022) Authors: Truyens, M; Lobaton, T; Peeters, A; Ferrante, M; Vermeire, S; Bossuyt, P; Pouillon, L; Dewint, P; Cremer, A; Peeters, H; Lambrecht, G; Louis, E; Rahier, J F; Dewit, O; Muls, V; Holvoet, T; Vandermeulen, L; Gonzales, G B; Laukens, D; De Vos, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P472 Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis. (21st January 2022) Authors: Le Cosquer, G; Capirchio, L; Rivière, P; de Suray, N; Poullenot, F; De Vroey, B; Berger, A; Denis, M A; Zerbib, F; Bachmann, R; Remue, C; Celerier, B; Leonard, D; Denost, Q; Kartheuser, A; Laharie, D; Dewit, O Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P496 Efficacy and safety of ustekinumab for chronic antibiotic refractory pouchitis: A Belgian open-label multicentre pilot study. (21st January 2022) Authors: Outtier, A; Louis, E; Dewit, O; Schops, G; Verstockt, B; Sabino, J; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P521 Effectiveness of ustekinumab as therapy for chronic antibiotic refractory pouchitis. (30th January 2023) Authors: Outtier, A; Louis, E; Dewit, O; Schops, G; Verstockt, B; Sabino, J; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P558 Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study. (21st January 2022) Authors: Cottron, C; Treton, X; Altwegg, R; Reenaers, C; Amiot, A; Fumery, M; Vuitton, L; Peyrin-Biroulet, L; Bouguen, G; Dewit, O; Nancey, S; Caillo, L; Roblin, X; Beylot-Barry, M; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P591 Negative impact of high body mass index on the efficacy of anti-TNFα agents in patients with Inflammatory Bowel Disease. (30th January 2023) Authors: Hamoir, F; De Leuze, F; Denis, M; De Vroey, B; De Suray, N; Burnet, G; Piessevaux, H; Dewit, O Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P694 Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients. (25th January 2019) Authors: Burnet, G; de Suray, N; De Vroey, B; Hoang, P; Coche, J-C; Denis, M; Gala, J-L; Dewit, O Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗